1. Home
  2. |Insights
  3. |Solicitor General Weighs in (Sort of) on Rule 9(b)

Solicitor General Weighs in (Sort of) on Rule 9(b)

Client Alert | 1 min read | 02.27.14

In October 2013, the Supreme Court invited the Solicitor General to express the government's views on a pending petition for certiorari in U.S. ex rel. Nathan v. Takeda Pharmaceuticals, whose central issue concerns the requisite level of particularity required by Rule 9(b) in FCA cases. The Solicitor General has now asked the Supreme Court to deny the relator's petition, calling the case "not a suitable vehicle" for resolving the particularity question (because the lower court reached the correct result on other grounds), while expressing the government's view that "a qui tam complaint satisfies Rule 9(b) if it contains detailed allegations supporting a plausible inference that false claims were submitted to the government, even if the complaint does not identify specific requests for payment"(emphasis added).


Insights

Client Alert | 4 min read | 11.20.26

CMS Seeks to "CRUSH” Fraud, Waste, and Abuse in Federal Health Programs

The Centers for Medicare & Medicaid Services (CMS) has released a proposed rule aimed at strengthening oversight of Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the ACA insurance exchanges. The proposal was published in The Federal Register on November 19, 2026. Most provisions would take effect 60 days after publication of a final rule unless a different date is specified.  ...